Trump Expected to Reclassify Marijuana to Schedule III, Boosting Cannabis Stocks

Potential Reclassification of Marijuana

• 📈 Cannabis stocks are soaring on reports that the President plans to reclassify marijuana from Schedule I to Schedule III.
• ⚠️ Currently, marijuana is classified as Schedule I, on par with heroin, while Schedule III is the same classification as Tylenol with codeine.
• 🗓️ Sources indicate the President is actively drafting an executive order to be issued as soon as Monday, advising the DOJ and DEA to move forward with reclassification.

Industry Optimism and Next Steps

• 💬 Tillray CEO Irwin Simon expressed optimism, believing this time is different from past promises and anticipating change by the end of the year.
• 📜 If an executive order is issued, the DOJ and DEA will publish a final rule, followed by a 30-day waiting period for challenges and potential litigation.
• ⚖️ A cannabis lawyer described this as the beginning of a "new era of public health policy," but a partial victory with legalization and regulatory hurdles still ahead.

Implications of Reclassification

• medical research. It is not legalization, but it opens the door for medical research and amplifies the use of cannabis for medical applications.
• 🌍 The demand seen in Europe and the potential for broader federal legalization for recreational use are long-term hopes for the industry.
• 🏦 Reclassification has major implications for health regulators, retailers, investors, and banks, contributing to the legitimization of the cannabis industry.